Bumper Offer - Urjas oil Just @ Rs. 1
Rifaximax 550 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Hepatic Encephalopathy. Rifaximax 550 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Rifaximax 550 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Rifaximax 550 Tablet are Flatulence, Bloating or fullness, Constipation. Besides the aforementioned side effects, there are other adverse effects of Rifaximax 550 Tablet as well, which are listed below. Such side effects of Rifaximax 550 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Rifaximax 550 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to Rifaximax 550 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
The section on Rifaximax 550 Tablet contraindications lists all such conditions.
Besides this, Rifaximax 550 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Rifaximax 550 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Rifaximax 550 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| 13 - 18 years (Adolescent) |
|
| Geriatric |
|
Is the use of Rifaximax 550 Tablet safe for pregnant women?
Rifaximax can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Rifaximax 550 Tablet safe during breastfeeding?
Rifaximax may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Rifaximax 550 Tablet on the Kidneys?
Using Rifaximax does not have any harmful effects on kidneys.
What is the effect of Rifaximax 550 Tablet on the Liver?
Rifaximax may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rifaximax 550 Tablet on the Heart?
Rifaximax is not harmful for the heart.
Rifaximax 550 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rifaximax 550 Tablet unless your doctor advises you to do so -
Is this Rifaximax 550 Tablet habit forming or addictive?
Rifaximax 550 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Rifaximax 550 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, but take Rifaximax 550 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Rifaximax 550 Tablet is not used to treat mental disorders.
Interaction between Food and Rifaximax 550 Tablet
Taking Rifaximax 550 Tablet with food does not harm your health.
Interaction between Alcohol and Rifaximax 550 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rifaximax 550 Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xifaxan® (rifaximin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 681-683
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1096-1097